XML 53 R67.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Plans - Share Based Compensation Activity (Detail) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used [Line Items]      
Outstanding Balance, Shares 3,088,519    
Stock options granted 168,916    
Exercised, Shares (1,687,918)    
Canceled, Shares (393,871)    
Outstanding Balance, Shares 1,175,646    
Exercisable Balance, Shares 764,693    
Outstanding Balance, Weighted Average Exercise Price $ 22.90    
Granted, Weighted Average Exercise Price $ 24.40    
Exercised, Weighted Average Exercise Price $ 19.97    
Canceled, Weighted Average Exercise Price $ 26.74    
Outstanding Balance, Weighted Average Exercise Price $ 26.02    
Exercisable Balance, Weighted Average Exercise Price $ 28.52    
Equity incentive plan restricted stock [Member]
     
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used [Line Items]      
Nonvested shares balance, Shares 633,647    
Granted, Shares 506,470    
Vested, Shares (214,598)    
Canceled, Shares (350,586)    
Nonvested shares balance, Shares 574,933 633,647  
Nonvested shares balance, Weighted Average Grant-Date Fair-Value $ 25.15    
Granted, Weighted Average Grant-Date Fair-Value $ 33.57 $ 33.26 $ 21.97
Vested, Weighted Average Grant-Date Fair-Value $ 20.80    
Canceled, Weighted Average Grant-Date Fair-Value $ 29.28    
Nonvested shares balance, Weighted Average Grant-Date Fair-Value $ 31.49 $ 25.15  
Long Term Incentive Plan Restricted Stock Units [Member]
     
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used [Line Items]      
Nonvested shares balance, Shares 281,500    
Granted, Shares 11,182    
Vested, Shares (273,307)    
Canceled, Shares (19,375)    
Nonvested shares balance, Shares       
Nonvested shares balance, Weighted Average Grant-Date Fair-Value $ 30.48    
Granted, Weighted Average Grant-Date Fair-Value       
Vested, Weighted Average Grant-Date Fair-Value $ 30.48    
Canceled, Weighted Average Grant-Date Fair-Value $ 30.48    
Nonvested shares balance, Weighted Average Grant-Date Fair-Value